The latest celebrity weight-loss drug to be given the nod in Hong Kong will be available in December, but experts cautioned ...

There's buzz around certain type 2 diabetes drugs, which not only help regulate blood sugar but can also lead to significant ...

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

Grapefruit can interact with many medications, potentially affecting the way they work or increasing side effects. Some of ...

Novo Nordisk addresses safety concerns surrounding compounded versions of its weight-loss and diabetes drugs, including ...

In interviews with Reuters, eight U.S. obesity specialists at universities and large health systems described a different ...

After years in shortage, weight loss and diabetes drugs Ozempic and Wegovy are now considered to be “available” by the Food ...

SGLT2 inhibitors and GLP-1 receptor agonists exhibit renoprotective effects in patients with CKD with and without diabetes.

Mumbai: A year-long study on managing type 2 diabetes (T2D) was published in the latest edition ... reducing dependency on ...

At the center of this fight is how the FDA regulates a possible "functional cure" for Type 1 diabetes and determines who gets ...

Geroscience has a long way to go, but there are four FDA-approved drugs that have shown promise to “target the process of ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy ...